These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16613580)

  • 1. Recent advances in anti-influenza agents with neuraminidase as target.
    Zhang J; Xu W
    Mini Rev Med Chem; 2006 Apr; 6(4):429-48. PubMed ID: 16613580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in rational drug design of neuraminidase inhibitors.
    Liu Y; Zhang J; Xu W
    Curr Med Chem; 2007; 14(27):2872-91. PubMed ID: 18045133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore model of influenza neuraminidase inhibitors--a systematic review.
    Gong JZ; Liu Y; Xu WF
    Pharmazie; 2009 Oct; 64(10):627-32. PubMed ID: 19947162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
    Chamni S; De-Eknamkul W
    Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuraminidase inhibitors as anti-influenza virus agents.
    Kim CU; Chen X; Mendel DB
    Antivir Chem Chemother; 1999 Jul; 10(4):141-54. PubMed ID: 10480735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor.
    Lew W; Chen X; Kim CU
    Curr Med Chem; 2000 Jun; 7(6):663-72. PubMed ID: 10702632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activity.
    Lew W; Wu H; Mendel DB; Escarpe PA; Chen X; Laver WG; Graves BJ; Kim CU
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3321-4. PubMed ID: 9873727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
    ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the structure-based design of neuraminidase inhibitors as antiinfluenza agents.
    Shan Y; Ma Y; Wang M; Dong Y
    Curr Med Chem; 2012; 19(34):5885-94. PubMed ID: 22963668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatic sialic acid analogues as potential inhibitors of influenza virus neuraminidase.
    Bianco A; Brufani M; Melchioni C
    Farmaco; 2001 Apr; 56(4):305-9. PubMed ID: 11421259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of aromatic inhibitors of influenza virus neuraminidase.
    Luo M; Air GM; Brouillette WJ
    J Infect Dis; 1997 Aug; 176 Suppl 1():S62-5. PubMed ID: 9240697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
    Huang L; Zhou JF; Wei H; Shu YL
    Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-influenza drugs and neuraminidase inhibitors.
    Roberts NA
    Prog Drug Res; 2001; Spec No():35-77. PubMed ID: 11548210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of (E)-1-amino-4-phenylbut-3-en-2-ol derivatives as novel neuraminidase inhibitors.
    Lu C; Yin Y; Meng F; Dun Y; Pei K; Wang C; Xu X; Wu F
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2003-2007. PubMed ID: 29748050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?
    Cheng CK; Tsai CH; Shie JJ; Fang JM
    Future Med Chem; 2014 May; 6(7):757-74. PubMed ID: 24941871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
    Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel acylhydrazone neuraminidase inhibitors.
    Zhao ZX; Cheng LP; Li M; Pang W; Wu FH
    Eur J Med Chem; 2019 Jul; 173():305-313. PubMed ID: 31022584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza neuraminidase.
    Air GM
    Influenza Other Respir Viruses; 2012 Jul; 6(4):245-56. PubMed ID: 22085243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
    Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
    J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity.
    Kim JH; Resende R; Wennekes T; Chen HM; Bance N; Buchini S; Watts AG; Pilling P; Streltsov VA; Petric M; Liggins R; Barrett S; McKimm-Breschkin JL; Niikura M; Withers SG
    Science; 2013 Apr; 340(6128):71-5. PubMed ID: 23429702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.